Cardiac assessment in chronic kidney disease

Current Opinion in Nephrology and Hypertension

Volumn 18, Issue 6, 2009, Pages 501-506

  Mclntyre, Chris W ^a,b   Odudu, Aghogho ^b   Eldehni, Mohamed T ^b  

^a DERBY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL DERBY HOSPITAL   (United Kingdom)

Author keywords

Cardiac imaging; Cardiac magnetic resonance imaging; Cardiovascular disease; Chronic kidney disease; Echocardiography

Indexed keywords

CONTRAST MEDIUM; DIPYRIDAMOLE; DOBUTAMINE;

CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE COURSE; EXERCISE ELECTROCARDIOGRAPHY; HEART FUNCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE ASYNERGY; HEART MUSCLE FIBROSIS; HEART SIZE; HEMODIALYSIS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; STUNNED HEART MUSCLE; SURVIVAL; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; CHRONIC DISEASE; DIAGNOSTIC IMAGING; DOPPLER ECHOCARDIOGRAPHY; HEART DISEASE; HEART FUNCTION TEST; HOSPITALIZATION; KIDNEY DISEASE; METHODOLOGY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTION AND FORECASTING; RENAL REPLACEMENT THERAPY; STRESS ECHOCARDIOGRAPHY;

CHRONIC DISEASE; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, STRESS; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; HEART DISEASES; HEART FUNCTION TESTS; HUMANS; KIDNEY DISEASES; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 73349136018     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328331050b     Document Type: Review

References (83)

1. Palmiero P, Maiello M, Nanda NC. Is echo-determined left ventricular geometry associated with ventricular filling and midwall shortening in hypertensive ventricular hypertrophy? Echocardiography 2008; 25:20-26.
2. Kizer JR, Bella JN, Palmieri V, et al. Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J 2006; 151:412-418.
3. Tripepi G, Benedetto FA, Mallamaci F, et al. Left atrial volume In end-stage renal disease: a prospective cohort study. J Hypertens 2006; 24:1173-1180.
4. Tripepi G, Benedetto FA, Mallamaci F, et al. Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study. J Am Soc Nephrol 2007; 18:1316-1322.
5. Barberato SH, Pecoits-Filho R. Usefulness of left atrial volume for the differentiation of normal from pseudonormal diastolic function pattern in patients on hemodialysis. J Am Soc Echocardiogr 2007; 20:359-365.
6. Barberato SH, Misocami M, Pecoits-Filho R. Association between left atrium enlargement and intradlalytlc hypotension: role of diastolic dysfunction in the hemodynamic complications during hemodialysis. Echocardiography 2009. [Epub ahead of print] This is the first study to directly link left atrial volume index to the risk of intradialytic hypotension.
7. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation 2008; 117:103-114.
8. This contemporary review eloquently describes the concepts of myocardial stunning and hibernation as a causative mechanism of heart failure, referencing all the seminal studies.
9. Selby NM, Lambie SH, Camici PG, et al. Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis 2006; 47:830-841.
10. Selby NM, Burton JO, Chesterton LJ, Mclntyre CW. Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol 2006; 1:1216-1225.
11. McIntyre CW, Burton JO, Selby NM, et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 2008; 3:19-26.
12. 15O PET scanning to demonstrate haemodialysis induced myocardial stunning in a patient group with no significant coronary artery disease.
13. Dasselaar JJ, Slart RHJA, Knip M, et al. Haemodialysis is associated with a pronounced fall in myocardial perfusion. Nephrol Dial Transplant 2009; 24:604-610.
14. 3 PET scanning to demonstrate haemodialysis-induced myocardial stunning in a patient group with no significant coronary artery disease.
15. Mclntyre CW. Effects of hemodialysis on cardiac function. Kidney Int 2009; 76:371-375.
16. Hung J, Lang R, Flachskampf F, et al. 3D echocardiography: a review of the current status and future directions. J Am Soc Echocardiogr 2007; 20:213-233.
17. Jacobs LD, Salgo IS, Goonewardena S, et al. Rapid online quantification of left ventricular volume from real-time three-dimensional echocardiography data. Eur Heart J 2006; 27:460-468.
18. Caiani EG, Corsi C, Sugeng L, et al. Improved quantification of left ventricular mass based on endocardial and epicardial surface detection with real time three dimensional echocardiography. Heart 2006; 92:213-219.
19. Jenkins C, Bricknell K, Hanekom L, Marwick TH. Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using realtime three-dimensional echocardiography. J Am Coll Cardiol 2004; 44:878-886.
20. Nikitin NP, Constantin C, Loh PH, et al. New generation 3-dimensional echocardiography for left ventricular volumetric and functional measurements: comparison with cardiac magnetic resonance. Eur J Echocardiogr 2006; 7:365-372.
21. Krenning BJ, Voormolen MM, Geleijnse ML, et al. Three-dimensional echocardiographic analysis of left ventricular function during hemodialysis. Nephron Clin Pract 2007; 107:c43-c49.
22. Van de Veire NR, De Sutter J, BaxJJ, Roelandt JRTC Technological advances in tissue Doppler imaging echocardiography. Heart 2008; 94:1065-1074.
23. Henein MY, Gibson DG. Normal long axis function. Heart 1999; 81:111-113.
24. Hayashi SY, Rohani M, Lindholm B, et al. Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging. Nephrol Dial Transplant 2006; 21:125-132.
25. Gulel O, Soylu K, Yuksel S, et al. Evidence of left ventricular systolic and diastolic dysfunction by color tissue Doppler imaging despite normal ejection fraction in patients on chronic hemodialysis program. Echocardiography 2008; 25:569-574.
26. Hayashi SY, Brodin LA, Alvestrand A, et al. Improvement of cardiac function after haemodialysis. Quantitative evaluation by colour tissue velocity imaging. Nephrol Dial Transplant 2004; 19:1497-1506.
27. Barberato SH, Mantilla DE, Misocami MA, et al. Effect of preload reduction by hemodialysis on left atrial volume and echocardiographic Doppler parameters in patients with end-stage renal disease. Am J Cardiol 2004; 94:1208-1210.
28. Galetta F, Cupisti A, Franzoni F, et al. Acute effects of hemodialysis on left ventricular function evaluated by tissue Doppler imaging. Biomed Pharmacother 2006; 60:66-70.
29. Fijalkowski M, Koprowski A, Gruchala M, et al. Effect of preload reduction by hemodialysis on myocardial ultrasonic characterization, left atrial volume, and Doppler tissue imaging in patients with end-stage renal disease. J Am Soc Echocardiogr 2006; 19:1359-1364.
30. Lee TY, Kang PL, Hsiao SH, et al. Tissue Doppler velocity is not totally preload-independent: a study in a uremic population after hemodialysis. Cardiology 2007; 107:415-421.
31. Drighil A, Madias JE, Mathewson JW, et al. Haemodialysis: effects of acute decrease in preload on tissue Doppler imaging indices of systolic and diastolic function of the left and right ventricles. Eur J Echocardiogr 2008; 9:530-535.
32. This study as well as reference [29] examines the difficult search for preload independent measures of ventricular function in haemodialysis whilst referencing the majority of recent relevant studies.
33. Palecek T, Skalicka L, Lachmanova J, et al. Effect of preload reduction by hemodialysis on conventional and novel echocardiographic parameters of left ventricular structure and function. Echocardiography 2008; 25:162-168.
34. This study as well as reference [28] examines the difficult search for preload independent measures of ventricular function in haemodialysis whilst referencing the majority of recent relevant studies.
35. Pellerin D, Sharma R, Elliott P, Veyrat C. Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function. Heart 2003; 89:1119-11117.
36. Skulstad H, Urheim S, Edvardsen T, et al. Grading of myocardial dysfunction by tissue Doppler echocardiography: a comparison between velocity, displacement, and strain imaging in acute ischemia. J Am Coll Cardiol 2006; 47:1672-1682.
37. Burns AT, McDonald IG, Thomas JD, et al. Doin'the twist: new tools for an old concept of myocardial function. Heart 2008; 94:978-983.
38. This contemporary review explains the concept and importance of ventricular torsion and the imaging methods used in its quantification.
39. Notomi Y, Setser RM, Shiota T, et al. Assessment of left ventricular torsional deformation by Doppler tissue imaging: validation study with tagged magnetic resonance imaging. Circulation 2005; 111:1141-1147.
40. Notomi Y, Lysyansky P, Setser RM, et al. Measurement of ventricular torsion by two-dimensional ultrasound speckle tracking imaging. J Am Coll Cardiol 2005;45:2034-2041.
41. Helle-Valle T, Crosby J, Edvardsen T, et al. New noninvasive method for assessment of left ventricular rotation: speckle tracking echocardiography. Circulation 2005; 112:3149-3156.
42. Thor E, Thomas H-V, Otto AS. Systolic dysfunction in heart failure with normal ejection fraction: speckle-tracking echocardiography. Prog Cardiovasc Dis 2006;49:207-214.
43. Pilmore H. Cardiac assessment for renal transplantation. Am J Transplant 2006; 6:659-665.
44. Rabbat CG, Treleaven DJ, Russell JD, et al. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis. J Am Soc Nephrol 2003; 14:431-439.
45. Fishbane S. Cardiovascular risk evaluation before kidney transplantation. J Am Soc Nephrol 2005; 16:843-845.
46. Fragasso G, Lu C, Dabrowski P, et al. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test. J Am Coll Cardiol 1999; 34:441-447.
47. Bates JR, Sawada SG, Segar DS, et al. Evaluation using dobutamine stress echocardiography in patients with insulin-dependent diabetes mellitus before kidney and/or pancreas transplantation. Am J Cardiol 1996; 77:175-179.
48. Herzog CA, Marwick TH, Pheley AM, et al. Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis 1999; 33:1080-1090.
49. Sharma R, Pellerin D, Gaze DC, et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant 2005; 20:2207-2214.
50. Sharma R, Mehta RL, Brecker SJ, et al. The diagnostic and prognostic value of tissue Doppler imaging during dobutamine stress echocardiography in endstage renal disease. Coron Artery Dis 2009; 20:230-237.
51. De Lima JJG, Sabbaga E, Vieira MLC, et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 2003; 42:263-268.
52. Karagiannis SE, Feringa HH, Elhendy A, et al. Prognostic significance of renal function in patients undergoing dobutamine stress echocardiography. Nephrol Dial Transplant 2008; 23:601-607.
53. Yuda S, Khoury V, Marwick TH. Influence of wall stress and left ventricular geometry on the accuracy of dobutamine stress echocardiography. J Am Coll Cardiol 2002; 40:1311-1319.
54. Bangalore S, Yao SS, Chaudhry FA. Usefulness of stress echocardiography for risk stratification and prognosis of patients with left ventricular hypertrophy. Am J Cardiol 2007; 100:536-543.
55. Douglas PS, Khandheria B, Stainback RF, et al. ACCF/ASE/ACEP/AHA/ ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance: endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine. Circulation 2008; 117:1478-1497.
56. Matsumura Y, Hozumi T, Aral K, et al. Noninvasive assessment of myocardial ischaemia using new real-time three-dimensional dobutamine stress echocardiography: comparison with conventional two-dimensional methods. Eur Heart J 2005; 26:1625-1632.
57. Eroglu E, D'Hooge J, Herbots L, et al. Comparison of real-time tri-plane and conventional 2D dobutamine stress echocardiography for the assessment of coronary artery disease. Eur Heart J 2006; 27:1719-1724.
58. Mor-Avi V, Lang RM. Three-dimensional echocardiographic evaluation of myocardial perfusion. Cardiol Clin 2007; 25:273-282.
59. Missouris CG, Forbat SM, Singer DR, et al. Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension. J Hypertens 1996; 14:1005-1010.
60. Mark PB, Patel RK, Jardine AG. Are we overestimating left ventricular abnormalities in end-stage renal disease? Nephrol Dial Transplant 2007; 22:1815-1819.
61. Milan A, Caserta MA, Dematteis A, et al. Blood pressure levels, left ventricular mass and function are correlated with left atrial volume in mild to moderate hypertensive patients. J Hum Hypertens 2009. [Epub ahead of print]
62. McGill RL, Biederman RW, Getts RT, et al. Cardiac magnetic resonance imaging in hemodialysis patients. J Nephrol 2009; 22:367-372.
63. This is one of the few studies that used CMR to study the morphological characteristics of the left ventricle in haemodialysis patients.
64. Hein S, Arnon E, Kostin S, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003; 107:984-991.
65. Nigri M, Azevedo CF, Rochitte CE, et al. Contrast-enhanced magnetic resonance imaging identifies focal regions of ntramyocardial fibrosis in patients with severe aortic valve disease: Correlation with quantitative histo-pathology. Am Heart J 2009; 157:361-368.
66. This study is the first to demonstrate a correlation between LGE and histological findings on myocardial biopsy taken at the time of valve replacement surgery.
67. Shriki JE, Surti K, Farvid A, et al. Quantitative evaluation of the amount of delayed myocardial enhancement as a predictor of systolic dysfunction. Open Cardiovasc Med J 2009; 3:35-38.
68. This study quantifies the mass of the myocardium with LGE and demonstrates its inverse relationship with ejection fraction.
69. Andrade JM, Gowdak LH, Giorgl MC, et al. Cardiac MRI for detection of unrecognized myocardial infarction in patients with end-stage renal disease: comparison with ECG and scintigraphy. AJR Am J Roentgenol 2009; 193:W25-32.
70. Kribben A, Witzke O, Hillen U, et al. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy. J Am Coll Cardiol 2009; 53:1621-1628.
71. Stewart GA, Mark PB, Johnston N, et al. Determinants of hypertension and left ventricular function in end stage renal failure: a pilot study using cardiovascular magnetic resonance imaging. Clin Physiol Funct Imaging 2004; 24: 387-393.
72. Hess AT, Zhong X, Spottiswoode BS, et al. Myocardial 3D strain calculation by combining cine displacement encoding with stimulated echoes (DENSE) and cine strain encoding (SENC) imaging. Magn Reson Med 2009; 62:77-84.
73. This study combines two MRI techniques to form a 3D map of the myocardial strain pattern.
74. Neizel M, Lossnitzer D, Korosoglou G, et al. Strain-encoded (SENC) magnetic resonance imaging to evaluate regional heterogeneity of myocardial strain in healthy volunteers: comparison with conventional tagging. J Magn Reson Imaging 2009; 29:99-105.
75. Russel IK, Tecelao SR, Kuijer JP, et al. Comparison of 2D and 3D calculation of left ventricular torsion as circumferential-longitudinal shear angle using cardiovascular magnetic resonance tagging. J Cardiovasc Magn Reson 2009; 11:8.
76. Rutz AK, Manka R, Kozerke S, et al. Left ventricular dyssynchrony in patients with left bundle branch block and patients after myocardial infarction: integration of mechanics and viability by cardiac magnetic resonance. Eur Heart J 2009. [Epub ahead of print]
77. Dutka DP, Camici PG. The contribution of positron emission tomography to the study of ischemic heart failure. Prog Cardiovasc Dis 2001; 43:399-418.
78. Schelbert HR, Phelps ME, Hoffman EJ, et al. Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. Am J Cardiol 1979; 43:209-218.
79. Khorsand A, Graf S, Eidherr H, et al. Gated cardiac 13N-NH3 PET for assessment of left ventricular volumes, mass, and ejection fraction: comparison with electrocardlography-gated 18F-FDG PET. J Nucl Med 2005; 46: 2009-2013.
80. Muzik O, Duvernoy C, Beanlands RS, et al. Assessment of diagnostic performance of quantitative flow measurements In normal subjects and patients with angiographically documented coronary artery disease by means of nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1998; 31:534-540.
81. Gould KL, Kirkeeide RL, Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 1990; 15:459-474.
82. Bengel FM, Higuchi T, Javadi MS, Lautamaki R. Cardiac positron emission tomography. J Am Coll Cardiol 2009; 54:1-15.
83. This review discusses the clinical applications of cardiac PET and the current available evidence for its use In assessing myocardial perfusion. It also highlights new developments and future clinical applications of cardiac PET.